Global Tissue Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Tissue Diagnostics Market Growth (Status and Outlook) 2023-2029

Tissue diagnostic procedures are majorly used for cancer diagnosis. Some of the major tissue diagnostic tests are immunochemistry (IHC), haematoxylin and eosin (H&E), and in situ hybridization (ISH)

LPI (LP Information)' newest research report, the “Tissue Diagnostics Industry Forecast” looks at past sales and reviews total world Tissue Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Tissue Diagnostics sales for 2023 through 2029. With Tissue Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tissue Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Tissue Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tissue Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tissue Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tissue Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tissue Diagnostics.

The global Tissue Diagnostics market size is projected to grow from US$ 4577.6 million in 2022 to US$ 6517.3 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.

Growing prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market over the forecast period. Tissue diagnostic involves monitoring, prognosis, and management of different stages of cancer, especially prostate cancer, gastric cancer and breast cancer. Furthermore, rising global geriatric population base, increasing demand for cost-effective and safe treatment and growing expenditure in the healthcare sector are other vital drivers of the tissue diagnostic market.

This report presents a comprehensive overview, market shares, and growth opportunities of Tissue Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Diagnostic Consumables
Diagnostic Instruments

Segmentation by application
Hospitals
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Agilent Technologies
Danaher
F. Hoffmann-La Roche
Sakura Finetek
Thermo Fisher Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.